✦ LIBER ✦

A single-arm confirmatory study of amrubicin therapy in patients with refractory small-cell lung cancer: Japan Clinical Oncology Group Study (JCOG0901)

✍ Scribed by Murakami, Haruyasu; Yamamoto, Nobuyuki; Shibata, Taro; Takeda, Koji; Ichinose, Yukito; Ohe, Yuichiro; Yamamoto, Noboru; Takeda, Yuichiro; Kudoh, Shinzoh; Atagi, Shinji; Satouchi, Miyako; Kiura, Katsuyuki; Nogami, Naoyuki; Endo, Masahiro; Watanabe, Hirokazu; Tamura, Tomohide

Book ID: 122124088
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 704 KB
Volume: 84
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2014.01.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of postoperative adjuvant

Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: The Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101)

✍ Ryosuke Tsuchiya; Kenji Suzuki; Yukito Ichinose; Yoh Watanabe; Tsutomu Yasumitsu 📂 Article 📅 2005 🏛 CTSNet 🌐 English ⚖ 202 KB

A phase II study of amrubicin and topote

A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401

✍ Nogami, Naoyuki; Hotta, Katsuyuki; Kuyama, Shoichi; Kiura, Katsuyuki; Takigawa, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 220 KB

A Phase 1 Study of Stereotactic Body Rad

A Phase 1 Study of Stereotactic Body Radiation Therapy (SBRT) for Peripheral T2N0M0 Non-Small Cell Lung Cancer (NSCLC): Japan Clinical Oncology Group Study (JCOG0702)

✍ Onimaru, R.; Shirato, H.; Shibata, T.; Hiraoka, M.; Ishikura, S.; Onishi, H.; Ka 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 47 KB

A randomized phase III study of irinotec

A randomized phase III study of irinotecan and cisplatin (CP) versus etoposide and cisplatin (EP) in extensive-disease small-cell lung cancer (ED-SCLC): Japan Clinical Oncology Group Study (JCOG 9511)

✍ Negoro, S; Noda, K; Nishiwaki, Y; Kawahara, M; Tamura, T; Sugiura, T; Yokayama, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

145 Effect of scheduling on clinical eff

145 Effect of scheduling on clinical efficacy of amrubicin (SM-5887) in patients with advanced non-small cell lung cancer (NSCLC): Single injection (the SM-5887 lung cancer study group) versus 3 consecutive day injection (the West Japan lung cancer group)

✍ Hida, T.; Sugiura, T.; Ikegami, H.; Kimura, I.; Ariyoshi, Y. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 146 KB

A Randomized Phase III Study of Single-A

A Randomized Phase III Study of Single-Agent Amrubicin Vs. Carboplatin/Etoposide in Elderly Patients With Extensive-Disease Small-Cell Lung Cancer

✍ Sekine, Ikuo; Okamoto, Hiroaki; Horai, Takeshi; Nakagawa, Kazuhiko; Ohmatsu, Hir 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 472 KB